People of the Hill Lab
Dr. Sarah Hill, M.D./Ph.D., is a physician scientist in the Department of Medical Oncology and Division of Molecular and Cellular Oncology at Dana-Farber Cancer Institute focused on understanding the mechanisms of ovarian carcinogenesis and therapeutic sensitivity and resistance. She completed her A.B. at Harvard College, her Ph.D. at Harvard University in the laboratory of Dr. David Livingston at Dana-Farber Cancer Institute, and her M.D. at Harvard Medical School in the Harvard-MIT HST program. She is also a Rhodes Scholar and completed an M.Sc. in biochemistry at Oxford University. Upon graduation from the Harvard M.D./Ph.D. program, she completed a brief residency in pathology. She joined the faculty at Dana-Farber as an independent investigator immediately upon completion of her residency without any post-doctoral training and won an NIH Early Independence Award with the support of her Ph.D. mentor Dr. Livingston.
|
Dr. Zelei Yang, Ph.D., is a Postdoctoral Research Fellow with research interest in women’s cancer. She obtained her B.S. Honors in Biochemistry from University of Alberta, Canada. She then completed her Ph.D. in Biochemistry also at University of Alberta, under co-supervision of Dr. David Brindley and Dr. Denise Hemmings. Her Ph.D. thesis focused on the effects of cytomegalovirus infection on breast cancer. By joining Dr. Hill’s lab, her research focus shifts toward ovarian cancer and specifically understanding of the tumor microenvironment. In her spare time, she enjoys reading novels, painting, and traveling around the world.
|
Dr. Saie Mogre, Ph.D. is a Postdoctoral Research Fellow with a deep interest in understanding the mechanisms of tumor progression and chemoresistance. She completed her Ph.D. from the Pennsylvania State University under the guidance of Dr. Adam Glick, where she studied the ER stress-dependent and independent roles of the UPR sensor IRE1alpha in the development of skin cancers. Concurrently, she obtained graduate certificates in Applied Statistics and Translational Sciences. Prior to her doctoral studies, she received her M.S. in Molecular and Cell Biology from Brandeis University, Waltham, MA, and B. Tech. in Biotechnology from Padmashree Dr. D. Y. Patil University, Navi Mumbai, India. In her free time, she likes to re-read the Harry Potter books, do Pilates, and seek occasional opportunities to perform Indian classical and Bollywood music as a vocalist.
Ms. Helena Jun is a computational biologist who completed an M.S. in Biomedical Informatics at the NYU Vilcek Institute of Graduate Biomedical Sciences, where she investigated drug response in autoimmune disease using longitudinal multi-modal single-cell data. She obtained her B.S. in Applied Biology and Chemistry at Seoul National University. Before her Master’s program, she spent one year in a Biomedical Informatics Lab at the Seoul National University Hospital, where her research focused on investigating cancer through bioinformatics analysis. In her free time, Helena enjoys practicing yoga, cooking, and exploring art museums.
Alumni
-Ms. Katherine Lynch-Research Assistant 2020-2022, Currently MD/PhD Program at the Icahn School of Medicine at Mount Sinai
-Mr. Ruiyang He (shared with CFCE)-Computational Biologist 2022-2023, Currently PhD Program Columbia University
-Ms. Katherine Lynch-Research Assistant 2020-2022, Currently MD/PhD Program at the Icahn School of Medicine at Mount Sinai
-Mr. Ruiyang He (shared with CFCE)-Computational Biologist 2022-2023, Currently PhD Program Columbia University
